COVID-19: Do not ignore basic parameters such as weight, height, and vital signs, especially in risk groups

- The COVID-19 pandemic poses major challenges to doctors and health systems worldwide. People with pre-existing health conditions have an even higher risk of experiencing a severe infection. Publications in medical journals and by independent organizations indicate that the exact measurement of vital parameters can play a major role in the treatment of risk groups with COVID-19. Height, weight, and vital signs such as blood pressure, oxygen saturation, pulse, and temperature are relevant for the exact dosage of medications and ventilator settings. In addition, this information helps with disease diagnosis and follow-up control measures.

The importance of nutritional status in COVID-19 management

Against the background of the current COVID-19 pandemic, the European Society for Clinical Nutrition and Metabolism (ESPEN) emphasizes in an expert statement the importance of nutritional status in high-risk groups, but also in people without pre-existing medical conditions. [1] The nutritional status of a person is closely related to the strength of the immune system and thus the ability of the body to fight infections. Elderly persons and people with pre-existing health conditions generally have a weaker immune system and often a relatively poor nutritional status. At the same time, they fall into the high-risk group for severe courses of a COVID-19 infection. Therefore, according to ESPEN, the analysis and assessment of nutritional status is particularly important in these patients.

However, this should also be taken into account for people without pre-existing conditions, as a stay in the intensive care unit – as may be necessary for a COVID-19 infection – can lead to malnutrition, with severe loss of skeletal muscle mass and function. This in turn can result in a poorer quality of life, disabilities and morbidity after discharge from the intensive care unit. This shows the importance of routine prevention, diagnosis, and treatment of malnutrition in the management of COVID-19.

Obesity and COVID-19

According to the ESPEN statement, obesity patients also belong to the high-risk group for critical COVID-19 infection courses, as overweight increases the severity of the disease. It is therefore necessary to thoroughly evaluate and address the nutritional status of obesity patients.

The World Obesity Federation also draws attention to the fact that obesity or obesity-related diseases increase the risk of severe COVID-19 progression. [2] In addition, the current pandemic could lead to a further increase in global obesity numbers: [3] treatment options for obesity patients (such as exercise programs, dietary advice and bariatric operations) have been severely curtailed. Furthermore, the lockdown restrictions have led to many people doing less exercise and consuming more processed foods with a longer shelf life or convenience foods. “During the current COVID-19 situation, there is a lack of support for obesity patients, such as advisory services for nutrition and exercise,” says Dr. Birgit Schilling-Massmann, general practitioner and head of a specialist practice for nutritional medicine in the Münster region. “As soon as we start easing the lockdown measures, these programs will need to be reinforced and provided with both political and financial support in order to reduce obesity rates and to relieve the health system in the long term.”

[1] Clinical Nutrition Journal. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. https: // Last access: 04/30/20

[2] World Obesity Federation. Coronavirus (COVID-19) & Obesity. Last access: 04/30/20

[3] World Obesity Federation. Obesity and COVID-19: Policy statement. Last access: 04/27/20

Press Contact seca gmbh & co. kg
Stefan Beyer, Head of Multi-Channel-Marketing
Tel.: +49 40 20 00 00 425

seca – precision for health
seca has been perfecting the skill of developing innovative weighing technologies and combining them with practice-oriented functions since 1840 and has become the worldwide market leader in the field of medical measuring and weighing. Apart from their sale in 16 branch offices, seca measuring systems and scales are also exported to over 110 countries. In addition, the seca service network guarantees the continual servicing of the precision devices. seca maintains close contact with users in order to support doctors and medical staff as professionally as possible. The result is innovative products that are customized to individual medical application areas such as interlinked weighing stations that communicate with each other, service and software systems that facilitate daily life in medicine and medical Body Composition Analyzers (mBCA) which revolutionize the possibility of diagnostics and therapy by use of bioelectrical impedance analysis. In doing so, the most advanced production techniques, durable materials, and worldwide quality management guarantee a product standard of the highest level.


Ota yhteyttä.

secan tiedotusosasto.

Oletko lehdistön edustaja, joka haluaisi tietoa yrityksestämme tai tuotteistamme? Ota yhteyttä secan viestintään.

Suomessa Teitä palvelee secan oma tytäryhtiö seca finland.

Tähdellä (*) merkityt kentät ovat pakollisia tietoja. Muut tiedot ovat vapaaehtoisia.

News Form fi

Individual Subject (grey)
standard fields (grey)

Tietosuojakäytäntömme koskevat tietoja.

Submit field